Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nicole Massoll

Concepts (246)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
9
2022
113
1.320
 Why?
Thyroid Nodule
5
2022
31
1.170
 Why?
Carcinoma, Papillary
4
2017
49
0.670
 Why?
Biopsy, Fine-Needle
7
2024
108
0.620
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
60
0.530
 Why?
Uterus
2
2008
91
0.530
 Why?
Papillomavirus Infections
2
2008
167
0.470
 Why?
Breast Neoplasms
7
2018
1187
0.390
 Why?
Vulvar Neoplasms
3
2008
58
0.360
 Why?
Carcinoma, Squamous Cell
4
2008
330
0.350
 Why?
Cysts
2
2006
51
0.330
 Why?
MicroRNAs
3
2022
349
0.330
 Why?
Uterine Cervical Neoplasms
2
2008
277
0.300
 Why?
Uterine Cervical Dysplasia
1
2008
49
0.300
 Why?
Precancerous Conditions
1
2008
83
0.290
 Why?
Carcinoma, Lobular
1
2007
33
0.280
 Why?
Cytological Techniques
1
2006
14
0.270
 Why?
Carcinoma, Ductal, Breast
1
2007
91
0.260
 Why?
Adenomyoma
1
2005
2
0.260
 Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.250
 Why?
Carcinoma in Situ
2
2008
73
0.250
 Why?
Gynecologic Surgical Procedures
1
2005
28
0.250
 Why?
Biopsy, Needle
1
2006
182
0.250
 Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
20
0.250
 Why?
Uterine Neoplasms
1
2005
60
0.250
 Why?
Lymph Nodes
3
2017
258
0.240
 Why?
Competency-Based Education
1
2024
28
0.240
 Why?
Carcinoma, Medullary
1
2004
12
0.230
 Why?
Humans
34
2024
50201
0.220
 Why?
Fellowships and Scholarships
1
2024
118
0.220
 Why?
Adenocarcinoma, Follicular
1
2002
4
0.210
 Why?
Mastectomy
2
2018
142
0.210
 Why?
Thyrotropin
1
2002
47
0.210
 Why?
Clinical Competence
1
2024
397
0.190
 Why?
Pathology
3
2024
38
0.190
 Why?
Female
21
2020
26829
0.180
 Why?
Focal Adhesion Kinase 1
2
2012
15
0.180
 Why?
Diagnostic Tests, Routine
1
2020
29
0.180
 Why?
Carcinoma, Neuroendocrine
1
2020
23
0.180
 Why?
Diagnosis, Differential
4
2008
1041
0.180
 Why?
Mutation
6
2022
1288
0.170
 Why?
Lung Neoplasms
2
2015
601
0.160
 Why?
DNA, Neoplasm
2
2018
146
0.160
 Why?
Protein Kinase Inhibitors
2
2012
205
0.160
 Why?
Proto-Oncogene Proteins B-raf
2
2017
78
0.160
 Why?
Immunohistochemistry
6
2015
973
0.150
 Why?
Thyroid Gland
3
2020
73
0.140
 Why?
Middle Aged
11
2020
12356
0.140
 Why?
Pancreatic Neoplasms
2
2010
209
0.140
 Why?
Gene Silencing
2
2008
114
0.140
 Why?
Neoplasm Invasiveness
5
2015
269
0.130
 Why?
DNA, Viral
2
2008
133
0.130
 Why?
Sensitivity and Specificity
4
2020
871
0.130
 Why?
PTEN Phosphohydrolase
1
2016
53
0.130
 Why?
Pulmonary Medicine
1
2015
15
0.130
 Why?
Fibroblasts
2
2016
352
0.130
 Why?
Cytodiagnosis
1
2015
42
0.130
 Why?
Aged, 80 and over
6
2020
3158
0.120
 Why?
Adult
10
2020
13486
0.120
 Why?
Cell Proliferation
4
2016
987
0.120
 Why?
Endosonography
1
2015
94
0.120
 Why?
Granuloma
2
2007
45
0.120
 Why?
Lymphatic Metastasis
3
2017
226
0.110
 Why?
Receptor, erbB-2
2
2018
74
0.110
 Why?
Laryngeal Diseases
1
2013
12
0.110
 Why?
Herpes Simplex
1
2013
21
0.100
 Why?
Laryngectomy
1
2013
27
0.100
 Why?
Purine Nucleosides
1
2012
3
0.100
 Why?
Receptor, IGF Type 1
1
2012
20
0.100
 Why?
Immunoenzyme Techniques
2
2008
141
0.090
 Why?
Cell Movement
2
2009
245
0.090
 Why?
Predictive Value of Tests
2
2020
921
0.090
 Why?
Receptors, Somatomedin
1
2010
8
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.080
 Why?
Tissue Fixation
2
2020
36
0.080
 Why?
Aniline Compounds
1
2009
42
0.080
 Why?
Retrospective Studies
5
2022
6190
0.080
 Why?
Melanoma
1
2012
281
0.080
 Why?
Promoter Regions, Genetic
2
2008
466
0.080
 Why?
Aged
6
2020
9505
0.080
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.080
 Why?
Neuroblastoma
1
2008
52
0.080
 Why?
Transglutaminases
1
2008
15
0.080
 Why?
Proto-Oncogene Proteins c-met
1
2007
19
0.070
 Why?
Mastitis
1
2007
3
0.070
 Why?
Biopsy
2
2007
592
0.070
 Why?
Genetic Markers
1
2008
103
0.070
 Why?
GTP-Binding Proteins
1
2008
92
0.070
 Why?
Genes, erbB-2
1
2007
8
0.070
 Why?
Prednisone
1
2007
101
0.070
 Why?
Gene Expression Regulation, Enzymologic
1
2008
178
0.070
 Why?
Group Practice
1
2006
3
0.070
 Why?
Intracellular Signaling Peptides and Proteins
1
2007
139
0.070
 Why?
Cystatins
1
2006
1
0.070
 Why?
Cadherins
1
2007
64
0.070
 Why?
Frozen Sections
1
2006
13
0.070
 Why?
Specialization
1
2006
46
0.070
 Why?
Genomic Instability
1
2007
91
0.070
 Why?
Colonic Neoplasms
1
2008
158
0.070
 Why?
Tumor Suppressor Protein p53
1
2008
214
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
579
0.070
 Why?
Polymerase Chain Reaction
2
2005
456
0.070
 Why?
Mice
6
2017
5673
0.070
 Why?
Medicine
1
2006
56
0.070
 Why?
Nuclear Proteins
1
2007
242
0.060
 Why?
RNA, Small Interfering
3
2012
210
0.060
 Why?
Carrier Proteins
1
2007
302
0.060
 Why?
Mullerian Ducts
1
2005
4
0.060
 Why?
Antigens, CD
1
2007
216
0.060
 Why?
Gene Expression
1
2008
612
0.060
 Why?
Fallopian Tubes
1
2005
22
0.060
 Why?
Medical Oncology
1
2006
96
0.060
 Why?
Estrogen Replacement Therapy
1
2005
28
0.060
 Why?
Signal Transduction
1
2012
1612
0.060
 Why?
Data Collection
1
2006
283
0.060
 Why?
Vulva
1
2005
17
0.060
 Why?
ABO Blood-Group System
1
2005
15
0.060
 Why?
Chromosome Aberrations
1
2007
295
0.060
 Why?
Ovariectomy
1
2005
113
0.060
 Why?
Glucocorticoids
1
2007
230
0.060
 Why?
Hysterectomy
1
2005
88
0.060
 Why?
Decision Making
1
2007
273
0.060
 Why?
Mice, Nude
3
2010
252
0.060
 Why?
Regression Analysis
1
2006
395
0.060
 Why?
Carcinoma, Transitional Cell
1
2005
52
0.060
 Why?
Epithelial Cells
1
2006
210
0.060
 Why?
Papillomaviridae
1
2005
102
0.060
 Why?
Male
7
2020
25572
0.060
 Why?
Cell Survival
3
2012
590
0.060
 Why?
Epigenesis, Genetic
1
2008
371
0.060
 Why?
Cell Line, Tumor
4
2009
1390
0.060
 Why?
Cohort Studies
2
2020
1414
0.060
 Why?
Ultrasonography
1
2006
438
0.060
 Why?
Prospective Studies
2
2022
2396
0.050
 Why?
Base Sequence
3
2010
653
0.050
 Why?
Gene Expression Regulation
1
2007
964
0.050
 Why?
Education, Medical, Graduate
1
2024
213
0.050
 Why?
Thyroidectomy
1
2002
59
0.050
 Why?
Gene Expression Profiling
1
2007
1029
0.050
 Why?
Adolescent
3
2015
6459
0.050
 Why?
Yersinia pseudotuberculosis
1
2001
4
0.050
 Why?
Animals
6
2017
13141
0.050
 Why?
Yersinia Infections
1
2001
6
0.050
 Why?
Yersinia enterocolitica
1
2001
6
0.050
 Why?
Recombinant Proteins
1
2002
480
0.050
 Why?
Combined Modality Therapy
1
2002
639
0.040
 Why?
Formaldehyde
1
2020
51
0.040
 Why?
Oncogenes
1
2020
57
0.040
 Why?
Appendicitis
1
2001
62
0.040
 Why?
Disease Progression
3
2008
821
0.040
 Why?
Cell Differentiation
1
2002
648
0.040
 Why?
Neoplasm Staging
2
2015
749
0.040
 Why?
Transplantation, Heterologous
2
2010
75
0.040
 Why?
Toxicology
1
1999
28
0.040
 Why?
Antineoplastic Agents
1
2008
1176
0.040
 Why?
Blotting, Western
2
2012
587
0.040
 Why?
DNA Methylation
3
2008
546
0.040
 Why?
DNA Primers
2
2010
207
0.040
 Why?
Young Adult
2
2020
4052
0.040
 Why?
Paraffin Embedding
1
2018
52
0.040
 Why?
Specimen Handling
1
2018
54
0.040
 Why?
Receptors, Progesterone
1
2018
63
0.040
 Why?
Receptors, Estrogen
1
2018
130
0.040
 Why?
Methylene Blue
1
2017
9
0.040
 Why?
Lymphatic System
1
2017
13
0.040
 Why?
Animals, Genetically Modified
1
2017
48
0.040
 Why?
Coloring Agents
1
2017
70
0.040
 Why?
Mice, Inbred Strains
1
2017
160
0.030
 Why?
Prognosis
2
2015
1963
0.030
 Why?
Follow-Up Studies
2
2015
2188
0.030
 Why?
Treatment Outcome
1
2006
5203
0.030
 Why?
Cost Savings
1
2015
58
0.030
 Why?
Apoptosis
2
2012
1093
0.030
 Why?
Mice, Knockout
2
2008
840
0.030
 Why?
Neoplasm Grading
1
2015
123
0.030
 Why?
RNA, Messenger
2
2008
1097
0.030
 Why?
Collagen
1
2016
208
0.030
 Why?
Cost-Benefit Analysis
1
2015
270
0.030
 Why?
Tumor Microenvironment
1
2016
222
0.030
 Why?
Immunoprecipitation
1
2012
58
0.030
 Why?
In Situ Nick-End Labeling
1
2012
52
0.030
 Why?
Flow Cytometry
1
2012
475
0.020
 Why?
Staurosporine
1
2009
12
0.020
 Why?
Cell Line
1
2012
1010
0.020
 Why?
Deoxycytidine
1
2009
28
0.020
 Why?
Drug Synergism
1
2009
152
0.020
 Why?
Cell Adhesion
1
2009
155
0.020
 Why?
RNA Interference
1
2009
178
0.020
 Why?
Xenograft Model Antitumor Assays
1
2009
212
0.020
 Why?
Polymorphism, Single-Stranded Conformational
1
2008
19
0.020
 Why?
Chromatin Immunoprecipitation
1
2008
48
0.020
 Why?
Luciferases
1
2008
50
0.020
 Why?
Adenoviridae
1
2008
49
0.020
 Why?
Florida
1
2008
58
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.020
 Why?
Fluorouracil
1
2008
55
0.020
 Why?
Loss of Heterozygosity
1
2008
77
0.020
 Why?
Histone Deacetylase 2
1
2007
4
0.020
 Why?
Phosphorylation
1
2009
525
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2008
102
0.020
 Why?
Transcriptional Activation
1
2008
121
0.020
 Why?
Co-Repressor Proteins
1
2007
18
0.020
 Why?
Estrogens
1
2009
222
0.020
 Why?
Sequence Deletion
1
2007
69
0.020
 Why?
Drug Screening Assays, Antitumor
1
2008
131
0.020
 Why?
Transfection
1
2008
354
0.020
 Why?
Molecular Chaperones
1
2007
63
0.020
 Why?
Histone Deacetylases
1
2007
50
0.020
 Why?
Enzyme Inhibitors
1
2009
378
0.020
 Why?
Ultrasonography, Mammary
1
2007
61
0.020
 Why?
Kaplan-Meier Estimate
1
2008
463
0.020
 Why?
Chromatin
1
2007
138
0.020
 Why?
Tumor Cells, Cultured
1
2007
462
0.020
 Why?
Transcription, Genetic
1
2008
369
0.020
 Why?
Cystatin M
1
2006
19
0.020
 Why?
Molecular Sequence Data
1
2008
795
0.020
 Why?
5' Untranslated Regions
1
2006
31
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Repressor Proteins
1
2007
149
0.020
 Why?
Down-Regulation
1
2007
342
0.020
 Why?
Carcinoma
1
2007
139
0.020
 Why?
Wound Healing
1
2007
203
0.020
 Why?
Cesarean Section
1
2007
185
0.020
 Why?
Protein Binding
1
2007
655
0.020
 Why?
Survival Rate
1
2008
906
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2009
824
0.020
 Why?
Chi-Square Distribution
1
2005
280
0.010
 Why?
Cells, Cultured
1
2008
1587
0.010
 Why?
Neoplasm Recurrence, Local
1
2008
630
0.010
 Why?
Pregnancy Complications
1
2007
381
0.010
 Why?
Child
2
2008
6862
0.010
 Why?
Tomography, X-Ray Computed
1
2007
1160
0.010
 Why?
Appendix
1
2001
23
0.010
 Why?
Infant, Newborn
1
2008
2770
0.010
 Why?
DNA, Bacterial
1
2001
187
0.010
 Why?
Magnetic Resonance Imaging
1
2007
1529
0.010
 Why?
Environmental Medicine
1
1999
1
0.010
 Why?
Occupational Medicine
1
1999
4
0.010
 Why?
History, Ancient
1
1999
10
0.010
 Why?
Pregnancy
1
2007
2609
0.010
 Why?
Forensic Medicine
1
1999
7
0.010
 Why?
History, 19th Century
1
1999
22
0.010
 Why?
Infant
1
2008
3584
0.010
 Why?
Risk Factors
1
2008
3644
0.010
 Why?
Child, Preschool
1
2008
3896
0.010
 Why?
History, 20th Century
1
1999
95
0.010
 Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (246) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department